Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

RhinoCyte is Profiled in this Database

Updated At 11 Mar, 2009

Start Free 7 Day Trial Now
Partial description of this company
Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of RhinoCyte plus 4917 other startups.

Start Free 7 Day Trial Now

Learn More About RhinoCyte

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png